Prot #CLEE011X2105: A Phase Ib/II, Multicenter, Study of LEE011 in Combination with LGX818 in Adult Patients with BRAF Mutant Melanoma

  • Kuzel, Timothy Michael (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date1/1/13 → 6/30/15

Funding

  • Novartis Pharmaceuticals Corporation (Prot #CLEE011X2105)